Site Search
Search Results
ACS CAN 2022 Montana Virtual Policy Briefing: Biomarker Testing - The Key to Precision Medicine
Pre-registration has now closed, but you can still join us the day of the event here: acscanbiomarkers.windrosemedia.com Biomarker testing is growing increasingly important in cancer ... individual patient’s unique disease. Timely access to appropriate biomarker testing can help achieve better health outcomes, improve quality of life and reduce costs by connecting patients to the most effective treatment for their cancer. Join ACS CAN for a virtual briefing about ...
Expand Access to Biomarker Testing in Colorado
Welcome! Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Coloradans can benefit from this important testing. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid. Biomarker testing is the ... ACS CAN in calling on the Colorado Legislature to expand access to biomarker testing. Key Resources : Fact Sheet Biomarker Testing and Cost Savings Patient Profiles ( www.fightcancer.org/biomarkerprofiles ) National Coalition Partners Types of Biomarker Testing Videos: Carla's ...
Expand Access to Biomarker Testing in Colorado
Welcome! Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Coloradans can benefit from this important testing. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid. Biomarker testing is the ... ACS CAN in calling on the Colorado Legislature to expand access to biomarker testing. Key Resources : Fact Sheet Biomarker Testing and Cost Savings Patient Profiles ( www.fightcancer.org/biomarkerprofiles ) National Coalition Partners Types of Biomarker Testing Videos: Carla's ...
Legislature Sends Incomplete Budget to Conference—No Increase in Tobacco Tax or Prevention Funding; Advocates Urge Enhancements
INDIANAPOLIS, IN – Today, the Indiana legislature passed the budget, sending it to the conference committee. Unfortunately, this version of the budget does not include increased tobacco taxes or funding for programs that help prevent tobacco use and help those already addicted quit. The following statement can be attributed to Allie Kast Gregg, American Cancer Society Cancer Action Network government relations director: “The budget passed by the ... funding for tobacco control. The American Cancer Society Cancer Action Network (ACS CAN) urges the conference committee to prioritize the health of Hoosiers by including a $2 per pack cigarette tax increase with a parallel tax on all other tobacco products, including e-cigarettes, and an ...
Cancer Advocates Denounce Today’s Action by House Judiciary Committee
... on by the full House. Senate Bill (SB) 21 would restrict minors from indoor tanning. The American Cancer Society Cancer Action Network (ACS CAN) and the Montana Academy of Dermatology speak out. In response to today’s defeat, Kristin Page-Nei, Montana government relations director for ACS CAN, ACS CAN volunteer/melanoma survivor Taelor Anderson, and Charlotte Kutsch, MD, President of Montana Academy of Dermatology released the following statements: Kristin Page-Nei, ACS CAN Montana Government Relations Director “For four ...
Tennessee Legislature and Governor Turn Their Backs on Cancer Patients
... TN – Today, Gov. Bill Lee signed the Medicaid block grant waiver into law over patient advocacy groups' objections. Emily Ogden, director of government relations in Tennessee for the American Cancer Society Cancer Action Network (ACS CAN), made the following statement in reaction. "For months, ACS CAN and other patient advocacy groups have voiced their concerns and objections to the approval of Tennessee's Medicaid 1115 Research and Demonstration waiver. This waiver will add additional barriers to health insurance coverage and ...
FDA Announces Inaugural Anti-Tobacco Public Education Campaign Targeting Youth
(ATLANTA) February 4, 2014 The American Cancer Society and ACS CAN are pleased that the Food and Drug Administration (FDA) is exercising its authority under the 2009 Family Smoking Prevention and Tobacco Control Act and undertaking a significant and high-profile effort to reach youth before they become addicted to nicotine. The äóÖReal Cost ' education campaign, which will include TV, radio and print ads in more than 200 media outlets, comes at a time when many people believe that ... all children and youth understand the immediate and long-term dangers they face from tobacco use. However, although there have been a number of recent successes in tobacco control, the release of the 2014 Surgeon General 's report on smoking last month is a reminder that 3,200 children ...
Opinion: Medicaid expansion is popular – and necessary
This opinion originally ran in Wausau Pilot & Review. By Philip R. O’Brien, national member of the ACS CAN Board of Directors In the Badger State, we have a proud tradition of taking care of each other when our friends and neighbors are struggling. ... without health insurance tend to be diagnosed a full stage later than insured individuals, marking a substantial difference in treatment cost. Expanding BadgerCare would cover cancer patients who currently do not have insurance. We need to acknowledge what rural, urban and suburban ...
Legislation Introduced to Increase Pennsylvanians’ Access to Biomarker Testing, the Key to Precision Medicine
... Mullins introduced House Bill 1754 to increase Pennsylvanians’ access to biomarker testing, following Sen. Devlin Robinson’s introduction of a companion bill, Senate Bill 954, in the Senate last week. A game-changing part of cancer care, biomarker testing opens the door to targeted therapy and personalized medicine which can improve patient survivorship and quality of life. This is a priority bill for the American Cancer Society Cancer Action Network (ACS CAN). ... do not cover the most appropriate biomarker testing. This results in some patients being forced to decide whether to pay out-of-pocket—a cost many cannot realistically afford--or go without the testing and hope the first treatment prescribed is the right one. Not all communities are ...
FAQs
Leadership Summit and Lobby Day > FAQs Thank you for registering to attend ACS CAN Leadership Summit & Lobby Day (LS&LD)! In preparation for your participation, below are the answers to some frequently asked questions about our event. What exactly is Leadership Summit & Lobby Day (LS&LD) LS&LD is an extraordinary opportunity to network, to learn, and most of all to represent the millions of people across our country who are impacted by this disease. During the Leadership Summit we prepare our ... auction, and Tuesday’s Hope Walk on the National Mall. What does ACS CAN provide related to the event? ACS CAN provides or covers the cost of all meals in transit to and from the event, as well as during the event itself; lodging in our host hotel; ground transportation, rail ...
Type
- Action (3) Apply Action filter
- Basic page (109) Apply Basic page filter
- Blog Post (85) Apply Blog Post filter
- Event (29) Apply Event filter
- Landing Page (1) Apply Landing Page filter
- Press Release (1141) Apply Press Release filter
- Resource (68) Apply Resource filter
- State Priority (106) Apply State Priority filter
- Update (662) Apply Update filter
Priority Issue
State
- National (232) Apply National filter
- Maine (123) Apply Maine filter
- Massachusetts (120) Apply Massachusetts filter
- New York (117) Apply New York filter
- Vermont (117) Apply Vermont filter
- New Jersey (59) Apply New Jersey filter
- Connecticut (51) Apply Connecticut filter
- California (47) Apply California filter
- Ohio (45) Apply Ohio filter
- Pennsylvania (43) Apply Pennsylvania filter
- Maryland (34) Apply Maryland filter
- North Carolina (33) Apply North Carolina filter
- Michigan (32) Apply Michigan filter
- Florida (29) Apply Florida filter
- Tennessee (26) Apply Tennessee filter
- Kentucky (25) Apply Kentucky filter
- New Mexico (25) Apply New Mexico filter
- West Virginia (25) Apply West Virginia filter
- South Carolina (24) Apply South Carolina filter
- Wyoming (24) Apply Wyoming filter
- Illinois (22) Apply Illinois filter
- Texas (22) Apply Texas filter
- Oklahoma (21) Apply Oklahoma filter
- Georgia (20) Apply Georgia filter
- Missouri (20) Apply Missouri filter
- South Dakota (20) Apply South Dakota filter
- Arizona (19) Apply Arizona filter
- Colorado (19) Apply Colorado filter
- Indiana (18) Apply Indiana filter
- Nevada (18) Apply Nevada filter
- Oregon (18) Apply Oregon filter
- Arkansas (17) Apply Arkansas filter
- Montana (16) Apply Montana filter
- New Hampshire (16) Apply New Hampshire filter
- Rhode Island (16) Apply Rhode Island filter
- North Dakota (15) Apply North Dakota filter
- Alabama (14) Apply Alabama filter
- Idaho (13) Apply Idaho filter
- Utah (13) Apply Utah filter
- Virginia (13) Apply Virginia filter
- Louisiana (12) Apply Louisiana filter
- Minnesota (12) Apply Minnesota filter
- Mississippi (11) Apply Mississippi filter
- Kansas (10) Apply Kansas filter
- Nebraska (10) Apply Nebraska filter
- Washington (10) Apply Washington filter
- Alaska (9) Apply Alaska filter
- District Of Columbia (9) Apply District Of Columbia filter
- Hawaii (9) Apply Hawaii filter
- Delaware (8) Apply Delaware filter
Policy Issue
- Access to Health Care (19) Apply Access to Health Care filter
- Research, Funding and Drug Development (8) Apply Research, Funding and Drug Development filter
- Prevention and Early Detection (7) Apply Prevention and Early Detection filter
- Health Equity (4) Apply Health Equity filter
- Patient Quality of Life (3) Apply Patient Quality of Life filter